For the Inventor, By the Inventor

Enter assignee name

Waltham, MA, United States of America

Alkermes Controlled Therapeutics, Inc.

USPTO Granted Patents = 46

CIPO Patents = 1

EPO Patents = 3

Forward Citations = 2,755

Loading Chart...

Loading Chart...

39 inventors (with patents filed for the assignee):

Mark A Tracy (19 out of 23 patents)

Howard Bernstein (14 out of 65 patents)

M Amin Khan (12 out of 15 patents)

4. Paul F Herbert (8 out of 12 patents)

5. Warren E Jaworowicz (7 out of 8 patents)

6. Michael S Healy (6 out of 7 patents)

7. OluFunmi Lily Johnson (6 out of 10 patents)

8. M Gary I Riley (5 out of 7 patents)

9. Paul A Burke (5 out of 12 patents)

10. Henry R Costantino (4 out of 84 patents)

11. Yan Zhang (4 out of 8 patents)

12. Kevin L Ward (4 out of 10 patents)

13. J Michael Ramstack (4 out of 44 patents)

14. Stephen E Zale (4 out of 50 patents)

15. Henry E Auer (4 out of 8 patents)

Core Competencies:

Injectable Suspensions

Sustained Release Microparticles

Biocompatible Polymer Blends

Targeted Delivery

Controlled Release

Microencapsulation

Submicron Particles

Biologically Active Agents

Protein Microspheres

Solid-Phase Particles

Human Growth Hormone

Metal Cation-Stabilized Interferon

46 patents: Sort by Forward Citations

1. 7799345 - Preparation of injectable suspensions having improved injectability (2010-09-21),

2. 7658998 - Method of preparing sustained release microparticles (2010-02-09),

3. 7371406 - Preparation of injectable suspensions having improved injectability (2008-05-13),

4. 7282216 - Biocompatible polymer blends and uses thereof (2007-10-16),

5. 7097857 - Methods and compositions for the targeted delivery of biologically active agents (2006-08-29),

6. 7089681 - Method and apparatus for filtering and drying a product (2006-08-15),

7. 7074432 - Method of modifying the release profile of sustained release compositions (2006-07-11),

8. 7037450 - Production scale method of forming microparticles (2006-05-02),

9. 6780434 - Controlled release of metal cation-stabilized interferon (2004-08-24),

10. 6749866 - Modulated release from biocompatible polymers (2004-06-15),

11. 6726860 - Production scale method of forming microparticles (2004-04-27),

12. 6713087 - Method of producing submicron particles of a labile agent and use thereof (2004-03-30),

13. 6667061 - Preparation of injectable suspensions having improved injectability (2003-12-23),

14. 6569458 - Process for producing small particles of biologically active molecules (2003-05-27),

15. 6565888 - Methods and compositions for the targeted delivery of biologically active agents (2003-05-20),

Alkermes Controlled Therapeutics, Inc. is a biopharmaceutical company focused on developing innovative drug delivery technologies. They specialize in controlled release formulations and transmucosal delivery systems to enhance the therapeutic efficacy of medications. With a strong focus on patient-centric solutions, Alkermes Controlled Therapeutics, Inc. aims to improve treatment outcomes and patient adherence. Their advanced technologies have potential applications in a wide range of therapeutic areas, including central nervous system disorders, oncology, and metabolic diseases.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

46 Patents

#26 in Waltham, MA

#420 in Massachusetts

#7,334 in US

#14,689 in the World

Waltham, MA, United States of America

Alkermes Controlled Therapeutics, Inc.

Forward Citations = 2,755

39 inventors:

Mark A Tracy (19 out of 23 patents)

Howard Bernstein (14 out of 65 patents)

M Amin Khan (12 out of 15 patents)

4. Paul F Herbert (8 out of 12 patents)

5. Warren E Jaworowicz (7 out of 8 patents)

Please report any incorrect information to support@idiyas.com

Loading…